Termi-Luc: a versatile assay to monitor full-protein release from ribosomes

Termination of protein biosynthesis is an essential step of gene expression, during which a complete functional protein is released from the ribosome. Premature or inefficient termination results in truncated, nonfunctional, or toxic proteins that may cause disease. Indeed, more than 10% of human genetic diseases are caused by nonsense mutations leading to premature termination. Efficient and sensitive approaches are required to study eukaryotic termination mechanisms and to identify potential therapeutics that modulate termination. Canonical radioactivity-based termination assays are complex, report on a short peptide release, and are incompatible with high-throughput screening. Here we describe a robust and simple in vitro assay to study the kinetics of full-protein release. The assay monitors luminescence upon release of nanoluciferase from a mammalian pretermination complex. The assay can be used to record time-progress curves of protein release in a high-throughput format, making it optimal for studying release kinetics and for high-throughput screening for small molecules that modulate the efficiency of termination.

[1]  V. Gladyshev,et al.  CTELS: A Cell-Free System for the Analysis of Translation Termination Rate , 2020, Biomolecules.

[2]  J. Pedersen,et al.  Hydrolysis. , 2020, Nature.

[3]  R. Green,et al.  Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides , 2019, bioRxiv.

[4]  F. He,et al.  Nonsense suppression position effect implicates poly(A)-binding protein in the regulation of translation termination , 2019 .

[5]  B. Cooperman,et al.  New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery. , 2018, ACS medicinal chemistry letters.

[6]  C. Hellen.  Translation Termination and Ribosome Recycling in Eukaryotes. , 2018, Cold Spring Harbor perspectives in biology.

[7]  E. Ziętkiewicz,et al.  Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons , 2018, Molecular medicine.

[8]  W. Tate,et al.  Eukaryotic translational termination efficiency is influenced by the 3′ nucleotides within the ribosomal mRNA channel , 2018, Nucleic acids research.

[9]  S. Joseph,et al.  Atomic mutagenesis of stop codon nucleotides reveals the chemical prerequisites for release factor-mediated peptide release , 2018, Proceedings of the National Academy of Sciences.

[10]  R. B. Altman,et al.  Aminoglycoside interactions and impacts on the eukaryotic ribosome , 2017, Proceedings of the National Academy of Sciences.

[11]  G. Brar.  Beyond the Triplet Code: Context Cues Transform Translation , 2016, Cell.

[12]  E. Alkalaeva,et al.  RNA helicase DDX19 stabilizes ribosomal elongation and termination complexes , 2016, Nucleic acids research.

[13]  J. Taunton,et al.  Decoding Mammalian Ribosome-mRNA States by Translational GTPase Complexes , 2016, Cell.

[14]  Hani S. Zaher,et al.  Uniformity of Peptide Release Is Maintained by Methylation of Release Factors. , 2016, Cell reports.

[15]  B. Eliseev,et al.  PABP enhances release factor recruitment and stop codon recognition during translation termination , 2016, Nucleic acids research.

[16]  James Inglese,et al.  Interferences with Luciferase Reporter Enzymes , 2016 .

[17]  Weibo Cai,et al.  NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence. , 2016, Bioconjugate chemistry.

[18]  Brock F. Binkowski,et al.  NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. , 2016, ACS chemical biology.

[19]  T. Becker,et al.  Structure of a human translation termination complex , 2015, Nucleic acids research.

[20]  Alan Brown,et al.  Structural basis for stop codon recognition in eukaryotes , 2015, Nature.

[21]  I. Tinoco,et al.  Mechanical force releases nascent chain–mediated ribosome arrest in vitro and in vivo , 2015, Science.

[22]  R. Green,et al.  Eukaryotic Release Factor 3 Is Required for Multiple Turnovers of Peptide Release Catalysis by Eukaryotic Release Factor 1* , 2013, The Journal of Biological Chemistry.

[23]  A. Korostelev,et al.  Blasticidin S inhibits translation by trapping deformed tRNA on the ribosome , 2013, Proceedings of the National Academy of Sciences.

[24]  A. Komar,et al.  Birth, life and death of nascent polypeptide chains , 2011, Biotechnology journal.

[25]  R. Green,et al.  Distinct response of yeast ribosomes to a miscoding event during translation. , 2011, RNA.

[26]  H. Noller,et al.  Recognition of the amber UAG stop codon by release factor RF1 , 2010, The EMBO journal.

[27]  Jianyu Zhu,et al.  Crystal structure of a translation termination complex formed with release factor RF2 , 2008, Proceedings of the National Academy of Sciences.

[28]  Sabine Petry,et al.  Insights into Translational Termination from the Structure of RF2 Bound to the Ribosome , 2008, Science.

[29]  H. Noller,et al.  Structural basis for translation termination on the 70S ribosome , 2008, Nature.

[30]  Matthew Mort,et al.  A meta‐analysis of nonsense mutations causing human genetic disease , 2008, Human mutation.

[31]  E. Youngman,et al.  Stop codon recognition by release factors induces structural rearrangement of the ribosomal decoding center that is productive for peptide release. , 2007, Molecular cell.

[32]  Lev L. Kisselev,et al.  In Vitro Reconstitution of Eukaryotic Translation Reveals Cooperativity between Release Factors eRF1 and eRF3 , 2006, Cell.

[33]  G. Dreyfuss,et al.  Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. , 2006, Genes & development.

[34]  M. Ehrenberg,et al.  A Posttermination Ribosomal Complex Is the Guanine Nucleotide Exchange Factor for Peptide Release Factor RF3 , 2001, Cell.

[35]  T. Merkulova,et al.  Translation termination in eukaryotes: polypeptide release factor eRF1 is composed of functionally and structurally distinct domains. , 2000, RNA.

[36]  M. Ehrenberg,et al.  The accuracy of codon recognition by polypeptide release factors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Blinov,et al.  Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish ability of human eRF1 to trigger peptidyl-tRNA hydrolysis. , 1999, RNA.

[38]  T. Merkulova,et al.  Functional expression of eukaryotic polypeptide chain release factors 1 and 3 by means of baculovirus/insect cells and complex formation between the factors. , 1998, European journal of biochemistry.

[39]  Koichi Ito,et al.  How protein reads the stop codon and terminates translation , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[40]  L. Kisselev,et al.  Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. , 1995, The EMBO journal.

[41]  E. V. Makeyev,et al.  Folding of firefly luciferase during translation in a cell‐free system. , 1994, The EMBO journal.

[42]  J. Davies,et al.  Misreading of RNA codewords induced by aminoglycoside antibiotics. , 1965, Molecular pharmacology.